Navigation Links
Cardiologists Tackle 'Next Frontier' in Cardiovascular Disease
Date:10/26/2007

DALLAS, Oct. 26 /PRNewswire-USNewswire/ -- The complex cases performed during this month's prestigious Transcatheter Cardiovascular Therapeutics symposium by Dr. Tony Das, an interventional cardiologist at Presbyterian Hospital of Dallas, represent the latest treatments for peripheral vascular disease, a looming health concern as the U.S. population ages and more Americans live with heart disease. The country's obesity epidemic will also dramatically increase the number of people with vascular disease in coming years, experts say.

"As we see more and more people living longer with heart disease, it affects other parts of the body, including their limbs, abdomen and cerebral vessels," Dr. Das said. "Now we're able to treat the condition in those regions of the body, which improves both the quality and quantity of life for these patients."

The procedures performed by Dr. Das -- a subclavian graft stent, an aortic stent, a femoral total occlusion with laser, and a below-knee total occlusion -- were broadcast live from Presbyterian Hospital of Dallas to the TCT symposium, attended by more than 12,000 physicians from around the world.

"These advances in the treatment of peripheral vascular disease are the next frontier in cardiovascular medicine," Dr. Das said.

Presbyterian Hospital of Dallas is one of only a handful of medical centers in the United States to broadcast live cases during the TCT symposium.

Peripheral vascular disease is a common condition affecting about 10 million adults in the U.S. The condition is a disease of blood vessels outside the heart and brain characterized by a narrowing of vessels that carry blood to the legs, arms, stomach and kidney. The condition may also include the build up of fatty deposits in the linings of artery walls. These blockages restrict blood circulation, which can damage tissue and lead to leg amputations.

The condition can sometimes be treated with medicines, but advanced cases may require angioplasty, a procedure to widen narrowed or blocked peripheral arteries. A wire mesh stent is then placed in the narrowed artery with a catheter.

"Without these advanced procedures, many of these patients would continue to get more and more sick, and some would face limb amputation and other life-threatening complications of the disease," said Dr. Kenneth Saland, an interventional cardiologist at Presbyterian Hospital of Dallas who assisted Dr. Das in the live cases.


'/>"/>
SOURCE Presbyterian Hospital of Dallas
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Next Safety, Inc.s Innovative Drug Delivery System Will Replace Cigarettes and Significantly Advance Pulmonary Medication Delivery
2. Medtronic Announces Positive Nine-Month Results for Endeavor Resolute Next Generation Drug-Eluting Stent at EuroPCR
3. Labtec’s Next Generation Pain Patch Successful in Clinical Studies
4. Kosan Presents Preclinical Antitumor and Safety Data On Next-Generation Epothilone KOS-1803 at AACR
5. Over 10,000 UK Breast Cancer Patients Could Become Eligible Within the Next Year for a Breast Cancer Therapy Showing Increased Survival Rates, Reveals Synovate Healthcare’s European Oncology Monitor
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. Phase IIIb Clinical Data Validate the Overall and Cardiovascular Safety Profile of Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) in Patients with Type 2 Diabetes
8. Byetta Treatment for Three and a Half Years Associated with Reductions in Cardiovascular Risk Factors in People with Type 2 Diabetes
9. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
10. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
11. Newly Published Data from Large Study Support Cardiovascular Safety of Avandia (Rosiglitazone Maleate)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... CRH) (NYSE MKT: CRHM) (the "Company"), announces that it will participate ... the Sheraton Hotel in Toronto, Ontario . ... is scheduled to present on Tuesday, May 2 at 10:00 am. ... the Board, Tony Holler will also attend the event. ... For more details about the ...
(Date:4/19/2017)... Global Surgical Drainage Device Market: Overview ... remove excess liquid and air. The fluid to be ... lymph. Surgical drains are used in a wide variety ... cardiovascular surgery, neurosurgery, plastic surgery etc. Common use of ... of fluid e.g. blood or pus. Surgical drains are ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
Breaking Medicine Technology:
(Date:4/27/2017)... Jacksonville, Florida (PRWEB) , ... April 27, 2017 , ... ... qualified candidates. But they will rapidly reject an outdated healthcare executive resume. , “If ... good look at your executive resume and wondering if it’s as ready as you ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... North American CAREGiverSM of the Year for her extraordinary compassion and lifelong dedication ... 60,000 North American professional caregivers for the prestigious award each year – identifying ...
(Date:4/27/2017)... ... ... Offering the purest product of its kind, Swissx Labs AG has launched ... the market has seen before. Swissx uses proprietary strains of hemp plants grown in ... for extraction, to produce its CBD oil--maximizing its benefits for health and wellness. Learn ...
(Date:4/26/2017)... ... April 26, 2017 , ... Jump Technologies, Inc., an ... it has completed a round of funding to accelerate its growth strategies. The ... Granite Capital is a growth equity firm focused on investments in healthcare and ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... to announce the ATA 2017 President’s Awards recipients, comprised of organizations and ... healthcare delivery. , The ATA 2017 President’s Awards recognize individuals and ...
Breaking Medicine News(10 mins):